Td Private Client Wealth LLC Editas Medicine, Inc. Transaction History

Td Private Client Wealth LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	SELL	$6.25 - $11.11 $3,250 - $5,777	-520 Closed	0 $0
Q3 2023 Aug 16, 2024	SELL	$6.92 - $9.31 $124 - $167	-18 Reduced 3.35%	520 $4.06 Million
Q3 2022 Aug 16, 2024	BUY	$12.16 - $19.42 $2,833 - $4,524	233 Added 76.39%	538 $6.59 Million
Q1 2022 Aug 16, 2024	BUY	$14.08 - $27.63 $4,294 - $8,427	305 New	305 $5.8 Million
Q4 2021 Aug 16, 2024	SELL	$26.55 - $40.57 $212 - $324	-8 Closed	0 $0
Q3 2021 Aug 16, 2024	BUY	$39.27 - $72.94 $314 - $583	8 New	8 $329,000
Q2 2021 Aug 16, 2024	SELL	$31.29 - $56.64 $344 - $623	-11 Closed	0 $0
Q1 2021 Aug 16, 2024	BUY	$39.71 - $90.58 $436 - $996	11 New	11 $462,000
Q1 2020 Aug 16, 2024	SELL	$14.88 - $32.78 $119 - $262	-8 Closed	0 $0
Q4 2019 Aug 16, 2024	BUY	$19.49 - $32.63 $155 - $261	8 New	8 $237,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.